Authors: Fassas, A Gojo, I Rapoport, A Cottler-Fox, M Meisenberg, B Papadimitriou, JC Tricot, G

Citation: A. Fassas et al., Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy, BONE MAR TR, 28(4), 2001, pp. 399-403

Authors: Karp, JE Lancet, JE Kaufmann, SH End, DW Wright, JJ Bol, K Horak, I Tidwell, ML Liesveld, J Kottke, TJ Ange, D Buddharaju, L Gojo, I Highsmith, WE Belly, RT Hohl, RJ Rybak, ME Thibault, A Rosenblatt, J

Citation: Je. Karp et al., Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial, BLOOD, 97(11), 2001, pp. 3361-3369

Authors: Gojo, I Tkaczuk, KH

Citation: I. Gojo et Kh. Tkaczuk, A phase I study of paclitaxel, UFT, and leucovorin, ONCOLOGY-NY, 14(10), 2000, pp. 76-78

Authors: Sarkodee-Adoo, C Gojo, I Heyman, MR

Citation: C. Sarkodee-adoo et al., von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome, N ENG J MED, 340(17), 1999, pp. 1368-1368